High-Intensity Exercise Training in Patients With Post-Infarction Heart Failure
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Introduction: Moderate-intensity endurance-training is known to reduce symptoms, increase exercise tolerance, and improve quality of life in patients with chronic heart failure. The training benefits have mainly been attributed to adaptations in the peripheral circulation and skeletal muscle rather than to adaptations in cardiac performance. However attenuation of left ventricular (LV) remodelling has been documented in some studies. The effects of high- vs. moderate exercise-intensity on LV-remodelling and endothelial function in patients with post-infarction heart failure are not definitively established and were studied in the present study.
Methods: Patients with post-infarction heart failure (45-87 yrs, 22-males, 5-females, all received b-blockers and ACE-inhibitors, EF 29%, peak oxygen uptake 13 ml/kg/min) were randomized to 12-weeks, 2-3 times per week, of either moderate exercise-intensity (70% of peak heart rate), high-intensity interval-training (95% of peak heart rate) or to a control group that received advise from their regular doctors. Patients in the two exercise-groups covered similar distance on the treadmill at each exercise-session so that only exercise-intensity differed; i.e. the duration of exercise was longer in the moderate-intensity group. Ultrasound was used to assess LV-dimension and function (including Tissue Doppler Imaging, TDI) and endothelial function in the brachial-artery.
| Condition | Intervention | Phase |
|---|---|---|
|
Heart Failure Myocardial Infarction Exercise Training |
Behavioral: Exercise training |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Factorial Assignment Masking: Single Blind Primary Purpose: Treatment |
| Official Title: | Anti-Remodeling Effect of High-Intensity Interval Training in Patients With Post-Infarction Heart Failure on Optimal Treatment |
Eligibility| Ages Eligible for Study: | 30 Years and older |
| Genders Eligible for Study: | Both |
Inclusion Criteria:
Post-infarction heart failure and optimal treatment (ACE-inhibitors, Beta-blockade)
Exclusion Criteria:
Not able to walk on a treadmill, unstable angina, participating in another experiment, serious arrhythmia
Contacts and Locations| Norway | |
| Norwegian University of Science and Technology | |
| Trondheim, Norway, 7489 | |
| Principal Investigator: | Ulrik Wisloff, Ph.D | Norwegian University of Science and Technology |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00218933 History of Changes |
| Other Study ID Numbers: | HFEX-1 |
| Study First Received: | September 20, 2005 |
| Last Updated: | October 23, 2008 |
| Health Authority: | Norway: Norwegian Social Science Data Services |
Keywords provided by Norwegian University of Science and Technology:
|
Interval training Endothelial dysfunction Aerobic capacity |
Additional relevant MeSH terms:
|
Heart Failure Infarction Myocardial Infarction Heart Diseases Cardiovascular Diseases |
Ischemia Pathologic Processes Necrosis Myocardial Ischemia Vascular Diseases |
ClinicalTrials.gov processed this record on May 21, 2013